{"id":"st-100-vezocolmitide","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL392303","moleculeType":"Small molecule","molecularWeight":"479.54"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the Wnt/β-catenin pathway, ST-100 (vezocolmitide) aims to reduce the proliferation of certain cancer cells. This mechanism is being explored for its potential to treat various types of cancer. Further research is needed to fully understand the effects of ST-100 (vezocolmitide) on this pathway.","oneSentence":"ST-100 (vezocolmitide) is a small molecule that modulates the Wnt/β-catenin signaling pathway.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:02.558Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic colorectal cancer"}]},"trialDetails":[{"nctId":"NCT06178679","phase":"PHASE3","title":"Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)","status":"UNKNOWN","sponsor":"ORA, Inc.","startDate":"2023-12-29","conditions":"Dry Eye Disease","enrollment":175}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ST-100 (vezocolmitide)","genericName":"ST-100 (vezocolmitide)","companyName":"ORA, Inc.","companyId":"ora-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ST-100 (vezocolmitide) is a small molecule that modulates the Wnt/β-catenin signaling pathway. Used for Metastatic colorectal cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}